Pricing Log in Create free account
Friday 6 November 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.

Revenue
+4.13%
EPS
−21.7%
Free cash flow
−63.7%

Quarter to September 2026, against a year earlier

564.88 43.61 −7.17%
Market cap
$24.3B
P/E
19.7×
Fwd P/E
22.5×
Dividend yield
—
F-score
8/9
Altman Z
19.55
Beneish M
−2.26
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

United Therapeutics Corporation (UTHR) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, United Therapeutics Corporation (UTHR) trades at a EV/Sales of 6.6×. Over the past ten years it has ranged from 1.7× (July 2019) to 7.6× (May 2026); the current reading is higher than 97% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.9× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.0× 31.07%
FY2024 4.5× 26.78%
FY2023 3.6× (34.79%)
FY2022 5.5× 5.07%
FY2021 5.2× 31.04%
FY2020 4.0× 79.59%
FY2019 2.2× (5.27%)
FY2018 2.3× (35.28%)
FY2017 3.6× 10.32%
FY2016 3.3× (23.26%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 6.2× (4.94%)
Jun 2026 6.6× (13.03%)
Mar 2026 7.6× 26.75%
Dec 2025 6.0× 17.29%
43 more quarters

Against its own ten years

Low 1.7× High 7.6×
Ten-year median 3.9×
Current reading's percentile 97

EV/Sales against peers

Company EV/Sales
VTRS Viatris Inc. compare 2.3×
HLN Haleon PLC Sponsored ADR compare 2.9×
ELAN Elanco Animal Health Incorporated compare 3.0×
TAK Takeda Pharmaceutical Co. compare 3.1×
TEVA Teva Pharmaceutical Industries Ltd. compare 3.6×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
NBIX Neurocrine Biosciences, Inc. compare 4.4×
ZTS Zoetis Inc. compare 4.5×
UTHR United Therapeutics Corporation 6.6×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on UTHR